Outbreak probe broadens as first patient sues compounding pharmacy

As a Minnesota woman became the first patient to sue New England Compounding over the meningitis outbreak suspected to have originated there, the company hired a prominent criminal-defense firm, and federal and state authorities stepped up their probes. According to the Centers for Disease Control and Prevention, 169 people have now been sickened in the outbreak, with a suspected 14,000 potentially exposed. Report

Suggested Articles

The future may be uncertain for AZ’s Imfinzi in first-line lung cancer, but its targeted med Tagrisso now boasts a green light in that setting.

Ultragenyx is back with another FDA nod, this time for Crysvita to treat X-linked hypophosphatemia in patients one year and older.

Roche got a two pieces of good Hemlibra news early this week—and what's good for Hemlibra must be good for Roche.